GLP-1RAs have now been shown to reduce consumption of alcohol and drugs, even treating addictions to gambling and sex, but these medications can also potentially lead to rare but fatal complications of which endocrinologists should be aware
What they basically did was take the GLP-1 molecule and make some molecular substitutions so that it would bind more strongly to albumin in blood and would last longer in circulation. The shift from injectable to oral formulations is another important development
[1] Exposure to elevated temperatures can denature the peptide structure, potentially reducing effectiveness or altering the safety profile
Both hold promise, but their side effects, advantages, and usage may vary
Given that MASLD and T2DM often coexist, various antidiabetic agents have been investigated as potential therapeutics for MASH
Dosing Convenience Be honest with yourself about your lifestyle